These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30459513)
41. Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement. Salter SM; Loh R; Sanfilippo FM; Clifford RM Allergy Asthma Clin Immunol; 2014; 10(1):49. PubMed ID: 25264449 [TBL] [Abstract][Full Text] [Related]
42. Survey of anaphylaxis management by general practitioners in Scotland. Lowe G; Kirkwood E; Harkness S Scott Med J; 2010 Aug; 55(3):11-4. PubMed ID: 20795510 [TBL] [Abstract][Full Text] [Related]
43. Patients' ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial. Umasunthar T; Procktor A; Hodes M; Smith JG; Gore C; Cox HE; Marrs T; Hanna H; Phillips K; Pinto C; Turner PJ; Warner JO; Boyle RJ Allergy; 2015 Jul; 70(7):855-63. PubMed ID: 25850463 [TBL] [Abstract][Full Text] [Related]
44. Anaphylaxis and epinephrine auto-injector training: who will teach the teachers? Grouhi M; Alshehri M; Hummel D; Roifman CM J Allergy Clin Immunol; 1999 Jul; 104(1):190-3. PubMed ID: 10400860 [TBL] [Abstract][Full Text] [Related]
45. A systematic review of patients', parents' and healthcare professionals' adrenaline auto-injector administration techniques. El Turki A; Smith H; Llewellyn C; Jones CJ Emerg Med J; 2017 Jun; 34(6):403-416. PubMed ID: 27466349 [TBL] [Abstract][Full Text] [Related]
46. What factors affect the carriage of epinephrine auto-injectors by teenagers? Macadam C; Barnett J; Roberts G; Stiefel G; King R; Erlewyn-Lajeunesse M; Holloway JA; Lucas JS Clin Transl Allergy; 2012 Feb; 2(1):3. PubMed ID: 22409884 [TBL] [Abstract][Full Text] [Related]
47. [EPIPEN INSTRUCTIONS FOR ANAPHYLAXIS PATIENTS DURING DISPENSING: FACTORS RELATED TO THE QUALITY OF PHARMACISTS' INSTRUCTIONS]. Kimura T; Suzuki S; Kumaki R; Kishimoto K; Uno T; Kaneko K; Nojo M; Shimamura M; Iwazumi E; Sato N; Tanaka A; Sagara H Arerugi; 2024; 73(3):279-289. PubMed ID: 38749712 [TBL] [Abstract][Full Text] [Related]
48. Anaphylaxis in an emergency department: a retrospective 10-year study in a tertiary hospital. Alen Coutinho I; Ferreira D; Regateiro FS; Pita J; Ferreira M; Martins JF; Fonseca IA; Loureiro C; Todo-Bom A Eur Ann Allergy Clin Immunol; 2020 Jan; 52(1):23-34. PubMed ID: 31287264 [No Abstract] [Full Text] [Related]
49. Adrenaline Auto-injector injuries to digits; a systematic review and recommendations for emergency management. Walsh K; Baker BG; Iyer S Surgeon; 2020 Oct; 18(5):305-310. PubMed ID: 32044290 [TBL] [Abstract][Full Text] [Related]
50. Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective. Simons E; Sicherer SH; Simons FE Ann Allergy Asthma Immunol; 2012 May; 108(5):321-5. PubMed ID: 22541402 [TBL] [Abstract][Full Text] [Related]
51. Drug-device combination products in the twenty-first century: epinephrine auto-injector development using human factors engineering. Edwards ES; Edwards ET; Simons FE; North R Expert Opin Drug Deliv; 2015 May; 12(5):751-62. PubMed ID: 25435244 [TBL] [Abstract][Full Text] [Related]
52. The importance of educating subjects entitled to use an adrenaline auto-injector for self-administration. Quercia O; Emiliani F; Stefanini B; Stefanini GF Eur Ann Allergy Clin Immunol; 2014 Nov; 46(6):237-8. PubMed ID: 25398170 [TBL] [Abstract][Full Text] [Related]
54. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan. Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799 [TBL] [Abstract][Full Text] [Related]
55. Does Informal Education Training Increase Awareness of Anaphylaxis among Students of Medicine? Before-After Survey Study. Leszkowicz J; Pieńkowska A; Nazar W; Bogdan E; Kwaka N; Szlagatys-Sidorkiewicz A; Plata-Nazar K Int J Environ Res Public Health; 2021 Aug; 18(15):. PubMed ID: 34360444 [TBL] [Abstract][Full Text] [Related]
56. Updated anaphylaxis guidelines: management in infants and children. Frith K; Smith J; Joshi P; Ford LS; Vale S Aust Prescr; 2021 Jun; 44(3):91-95. PubMed ID: 34211247 [TBL] [Abstract][Full Text] [Related]
57. Adverse drug reactions from adrenaline auto-injectors: Analysis of the French pharmacovigilance database. Pouessel G; Petitpain N; Tanno LK; Gautier S; Clin Exp Allergy; 2023 Sep; 53(9):955-958. PubMed ID: 37464961 [No Abstract] [Full Text] [Related]
58. Epinephrine auto-injector use and demographics in a Veterans Administration population. Amirzadeh A; Verma P; Lee S; Klaustermeyer W Allergy Asthma Proc; 2010; 31(4):304-7. PubMed ID: 20819320 [TBL] [Abstract][Full Text] [Related]
59. Service evaluation of laceration risk using trainer adrenaline auto-injectors. Pike LC; Tuthill D Arch Dis Child; 2021 Jan; 106(1):54-57. PubMed ID: 32816690 [TBL] [Abstract][Full Text] [Related]
60. Effectiveness of epinephrine auto-injector skill training for school nurses. Shiraishi Y; Ishikawa Y; Shiraishi Y; Matsumura M J Gen Fam Med; 2020 Jan; 21(1):30-31. PubMed ID: 31911888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]